SMTL ID : 5hvf.1

Crystal Structure of Thrombin-activatable Fibrinolysis Inhibitor in Complex with an Inhibitory Nanobody (VHH-i83)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.85 Å
Oligo State
hetero-1-1-mer
Ligands
1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x ZN: ZINC ION(Non-covalent)
1 x FLC: CITRATE ANION(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Zhou, X. et al., Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity. J.Thromb.Haemost. (2016)
Release Date
2016-06-22
Peptides
Carboxypeptidase B2: A
VHH-i83: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Carboxypeptidase B2

VHH-i83

Related Entries With Identical Sequence

5hvg.1 | 5hvg.2 | 5hvh.1